Gilead Sciences stock trades 0.17 percent above its Xetra close of EUR 134.84
Published on 10/10/2026 at 10:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Gilead Sciences stock was EUR 135.07 in weekend trading on October 10, 2026.
- The price was EUR 134.84 at the close of October 9.
- Gilead announced a regional lenacapavir access agreement with PAHO on September 15.
Gilead Sciences stock was EUR 135.07 in weekend trading at Lang & Schwarz at 10:23 a.m. CEST on October 10, 2026, up 0.17 percent versus the EUR 134.84 close at Lang & Schwarz on October 9.
Weekend trading
The bid was EUR 134.94 and the ask was EUR 135.20 at Lang & Schwarz. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Gilead Sciences stock.
The week in figures
Gilead Sciences closed at EUR 134.84 at Lang & Schwarz on October 9. The weekend indication was EUR 135.07 on October 10, while the quote page recorded EUR 131.21 as an earlier comparison level on October 9. The current indication therefore stood EUR 0.23 above the prior close.
Chronology of the week
On October 7, Gilead Sciences was reported at EUR 132.57 after EUR 128.09. On October 9, the stock was reported at EUR 134.95 against EUR 131.21. These figures are dated market indications from the company topic page.
Company development
On September 15, Gilead Sciences announced an agreement with the Pan American Health Organization to accelerate access to twice-yearly lenacapavir for HIV prevention across all PAHO member states in Latin America and the Caribbean. The company said the agreement creates a regional pathway through PAHO's Regional Revolving Funds and covers 14 countries outside its voluntary licensing agreements. Gilead Investor Relations published the announcement.
Market context: Market report S&P 500.
Dates of the coming week
The next Xetra session is scheduled for October 12, 2026.
